87% of COVID-19 vaccines were supplied to northern countries, while only 0.2% was distributed to low-income countries.

Omissions

• The 87% / 0.2% figures are from early 2021 (WHO briefing, April 2021); the MEP presented them in 2026 without a time reference, so they should not be read as the current distribution.
• The distribution evolved markedly after 2021: low-income countries received a growing share of doses through 2022-2023, so the 0.2% figure is a historical rather than current datum.
• The most recent source located (August 2025) still cites the 2021/2022 pandemic-era figures and does not publish a 2025 distribution-by-income-group share; no more recent official distribution share was found.
• The claim is verified only through a single secondary source (UN News reporting a WHO briefing); no primary WHO/COVAX dataset with these exact two figures was retrieved.

Sources

• SecondaryUN News (reporting WHO briefing, Tedros Adhanom Ghebreyesus)"Although more than 700 million vaccine doses have been administered globally, richer countries have received more than 87 per cent, and low-income countries just 0.2 per cent."
• SecondaryThe Regulatory Review"In 2021, 70 percent of COVID-19 vaccines produced went to high-income countries while less than four percent made it to low-income countries. By 2022, less than nine percent of people in low-income countries received at least one dose of a vaccine while 60 percent of people in high-income countries received a dose."